EuroEyes expects H1 loss attributable to owners of HK$10 million-HK$17 million vs HK$38.4 million profit a year earlier

• EuroEyes guided to an owner-attributable loss of HK$10 million to HK$17 million for H1 ended June 30, 2026.
• Compares with owner-attributable profit of about HK$38.4 million a year earlier.
• Revenue expected at HK$450 million to HK$460 million, up 19% to 22% from HK$377.1 million.
• Profit swing driven by one-off FYEO Europe B.V. acquisition costs; Switzerland unit losses amid a turnaround.
• FYEO deal closed July 22, 2026; contribution expected from the second half of fiscal 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Euroeyes International Eye Clinic Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260824-12297061), on August 24, 2026, and is solely responsible for the information contained therein.